"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
DOSAGE AND ADMINISTRATION
Apply a thin film of Pandel (hydrocortisone probutate cream) Cream, 0.1% to the affected area once or twice a day depending on the severity of the condition. Massage gently until the medication disappears.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Pandel (hydrocortisone probutate cream) Cream, 0.1% should not be used with occlusive dressings unless directed by the physician. Pandel (hydrocortisone probutate cream) Cream, 0.1% should not be applied in the diaper area, as diapers or plastic pants may constitute occlusive dressings.
Pandel (hydrocortisone probutate cream) Cream, 0.1%, a white to off-white opaque cream is supplied as follows:
15 gtubes NDC 64682-200-15
45 g tubes NDC 64682-200-46
80 g tubes NDC 64682-200-80
Store at controlled room temperature 15°-30°C (59°-86°F).
Manufactured for: CollaGenex Pharmaceuticals, Inc. Newtown, PA 18940 by Altana Inc., Melville, New York 11747. FDA revision date: 2/28/1997This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/24/2008
Additional Pandel Information
Pandel - User Reviews
Pandel User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.